Current applications of polysaccharides in colon targeting

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 13, Issue 3-4, 1996, Pages 185-223

  Hovgaard, Lars ^a   Brøndsted, Helle ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

biodegradation; colon specific drug delivery; colonic microflora; drug delivery systems; polysaccharidases; polysaccharide fermentation

Indexed keywords

AMYLOSE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ARABINOGALACTAN; CHITOSAN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHONDROITIN SULFATE; CYCLODEXTRIN; DEXAMETHASONE; DEXTRAN; GALACTOMANNAN; GLYCOSIDASE; INDOMETACIN; INSULIN; INTESTINE ENZYME; LAXATIVE; METHYLPREDNISOLONE; NAPROXEN; PECTIN; POLYMER; POLYSACCHARIDE; POLYSACCHARIDE LYASE; PRODRUG; SHORT CHAIN FATTY ACID; VACCINE; XYLAN;

ARTICLE; BACTERIAL METABOLISM; CARBOHYDRATE METABOLISM; COLON; COLON FLORA; CONTROLLED RELEASE FORMULATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG TARGETING; ENZYME DEGRADATION; FILM COATING; GAMMA SCINTIGRAPHY; HYDROGEL; MACROMOLECULE; NONHUMAN; TISSUE SPECIFICITY;

EID: 0030469774     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.v13.i3-4.10     Document Type: Article

References (104)

1. Danishefsky, I., Whistler, R. L., and Bettelheim, F. A., Introduction to polysaccharides chemistry, in The Carbohydrates, Vol. 2 A, Pigman, W., Horton, D., and Herp, A., Eds., Academic Press, New York, 1970, 375.
2. Aspinall, G. O., General introduction, in The Polysaccharides, Vol. 1, Aspinall, G. O., Ed., Academic Press, New York, 1982, 1.
3. Aspinall, G. O., Isolation and fractionation of polysaccharides, in The Polysaccharides, Vol. 1, Aspinall, G. O., Ed., Academic Press, New York, 1982, 19.
4. Ward, K., Jr. and Seib, P. A., Cellulose, lichenan, and chitin, in The Carbohydrates. Vol. 2 A, Pigman, W., Horton. D., and Herp, A., Eds., Academic Press, New York, 1970, 413.
5. Whistler, R. L. and Richards, E. L., Hemicelluloses, in The Carbohydrates, Vol. 2 A, Pigman, W., Horton, D., and Herp, A., Eds., Academic Press, New York, 1970, 447.
6. Greenwood, C. T., Starch and glycogen, in The Carbohydrates, Vol. 2 B, Pigman, W., Horton, D., and Herp, A., Eds., Academic Press, New York, 1970, 471.
7. Aspinall, G. O., Pectins, plant gums, and other plant polysaccharides, in The Carbohydrates, Vol. 2 B, Pigman, W., Horton, D., and Herp, A., Eds., Academic Press, New York, 1970, 515.
8. Percival, E., Algal polysaccharides, in The Carbohydrates, Vol. 2 B, Pigman, W., Horton, D., and Herp, A., Eds., Academic Press, New York, 1970, 537.
9. Barker, S. A. and Somers, P. J., Bacterial and fungal polysaccharides. in The Carbohydrates, Vol. 2 B, Pigman, W., Horton, D., and Herp, A., Eds., Academic Press, New York, 1970, 569.
10. Jeanloz, R. W., Mucopolysaccharides of higher animals, in The Carbohydrates, Vol. 2 B, Pigman, W., Horton, D., and Herp, A., Eds., Academic Press, New York, 1970, 590.
11. Sandford, P. A. and Baird, J., Industrial utilization of polysaccharides, in The Polysaccharides, Vol. 2, Aspinall, G. O., Ed., Academic Press, New York, 1982, 411.
12. Bettini, R., Colombo, P., Massimo, G., Catellani, P. L., and Vitali, T., Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects, Eur. J. Pharmacol. Sci., 2, 213, 1994.
13. Melia, C. D., Hydrophilic matrix sustained release systems based on polysaccharide carriers, Crit. Rev. Ther. Drug Carrier Syst., 8, 395, 1991.
14. Larsen, C., Dextran Prodrugs: Physicochemical and Chemical Aspects in Relation to In Vivo Properties, FADL, Copenhagen, 1990.
15. Schact, E., Vandoorne, F., Vermeersch, J., and Duncan, R., Polysaccharides as drug carriers, in Controlled Release Technology, Lee, P. I. and Good, W. R., Eds., American Chemical Society, Washington, D.C., 1987, 188.
16. Sezaki, H. and Hashida, M., Macromolecule-drug conjugates in targeted cancer chemotherapy, Crit. Rev. Ther. Drug Carrier Syst., 1, 1, 1984.
17. Okano T., Yui, N., Yokoyama, M., and Yoshida, R., Advances in Polymeric Systems for Drug Delivery, Gordon and Breach Science Publishers, Japan, 1994, 24.
18. Sunamoto, J. and Iwamoto, K., Protein-coated and polysaccharide-coated liposomes as drug carriers, Crit. Rev. Ther. Drug Carrier Syst., 2, 117, 1987.
19. Jones, M. N., Carbohydrate-mediated liposomal targeting and drug delivery, Adv. Drug Del. Rev., 13, 215, 1994.
20. Lancaster, C. M. and Wheatley, M. A., Drug delivery to the colon: polymer susceptibility to degradation by colon contents, Polymer Preprints, American Chemical Society, Dallas, 1988, 480.
21. Gruber, P., Longer, M. A., and Robinson, J. R., Some biological issues in oral, controlled drug delivery. Adv. Drug Del. Rev., 1, 1, 1987.
22. Macfarlane, G. T. and Cummings, J. H., The colonic flora, fermentation, and large bowel digestive function, in The Large Intestine: Physiology, Pathophysiology, and Disease, Phillips, S. F., Pemberton. J. H., and Shorter, R. G., Eds., Raven Press, New York, 1991, 51.
23. Gazzaniga, A., Iamartino, P., Maffione, G., and Sangalli, M. E., Oral delayed-release system for colonic specific delivery, Int. J. Pharmacol., 108, 77, 1994.
24. Steed, K. P., Hooper, G., Ventura, P., Musa, R., and Wilding, I. R., The in vivo behavior of a colonic delivery system: a pilot study in man. Int. J. Pharmacol., 112, 199, 1994.
25. Friend, D. R., Colon-specific drug delivery, Adv. Drug Del. Rev., 7, 149, 1991.
26. Friend, D. R., Ed., Oral Colon-Specific Drug Delivery, CRC Press, Boca Raton, 1992.
27. Bieck, P. R., Ed., Colonic Drug Absorption and Metabolism. Marcel Dekker, New York, 1993.
28. Martindale, The Extra Pharmacopoeia, 30th Ed., Reynolds, J. E. F., Ed., Pharmaceutical Press, London, 1993.
29. Ikesue, K., Kopeckova, P., and Kopecek, J., Degradation of proteins by guinea pig intestinal enzymes. Int. J. Pharmacol., 95, 171, 1993.
30. Mitsouka, T., Intestinal Bacteria and Health, Harcourt Brace Jovanovich, Tokyo, 80, 1978.
31. Hardy, J. G., Wilson, C. G., and Wood, E., Drug delivery to the proximal colon, J. Pharm. Pharmacol., 37, 874, 1985
32. McLeod, A. D. and Tozer, T. N., Kinetic perspectives in colonic drug delivery, in Oral Colon-Specific Drug Delivery, Friend, D. R., Ed., CRC Press, Boca Raton, 1992, 85.
33. Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., and Hardcastle, J. D., Measurement of gastrointestinal pH profiles in normal ambulant human subjects, Gut, 29, 1035, 1988.
34. Kenyon, C. J., Cole, E. T., and Wilding, I. R., The effect of food on the in vivo behavior of enteric coated starch capsules, Int. J. Pharmacol., 112, 207, 1994.
35. Adkin, D. A., Davis, S. S., Sparrow, R. A., and Wilding, I. R., Colon transit of different sized tablets in healthy subjects, J. Control. Rel., 23 147, 1993.
36. Dew, M. J., Hughes, P. J., Lee, M. G, Evans, B. K., and Rhodes, J., An oral preparation to release drugs in the human colon, Br. J. Clin. Pharmacol., 14, 405, 1982.
37. Thomas, P., Richards, D., Richards, A., Rogers, L., Evans, B. K., Dew, M. J., and Rhodes, J., Absorption of delayed release dependent polymers for colonic targeting, Int. J. Pharmacol., 37, 757, 1985.
38. Ashford, M., Fell, J. T., Attwood, D., and Woodhead, P. J., An in vitro investigation into the suitability of pH-dependent polymers for colonic targeting, Int. J. Pharmacol., 91, 241, 1993.
39. Simon, G. L. and Gorbach, S. L., Bacteriology of the colon, in Colon: Structure and Function, Bustos-Fernandez, L., Ed., Plenum Medical Book Company, New York, 1983, 103.
40. Hawksworth, G., Drasar, B. S., and Hill, M. J., Intestinal bacteria and hydrolysis of glycosidic bonds, J. Med. Microbiol., 4, 451, 1971.
41. Rowland, I. R., Factors affecting metabolic activity of the intestinal microflora, Drug Metabol. Rev., Marcel Dekker, New York, 19, 243, 1988.
42. Rubinstein, A., Microbially controlled drug delivery to the colon, Biopharm. Drug Disp., 11, 465, 1990.
43. Ryde, E. M., Low molecular weight azo compounds, in Oral Colon-Specific Drug Delivery, Friend, D. R., Ed, CRC Press, Boca Raton, 1992, 143.
44. Saffran, M., Kumar, G. S., Savariar, C., Burnham, J. C., Williams, F., and Neckers, D. C., A new approach to the oral administration of insulin and other peptide drugs, Science, 233, 1981, 1986.
45. Brøndsted, H. and Kopecek, J., Hydrogels for site-specific oral drug delivery: synthesis and characterization, Biomaterials, 12, 584, 1991.
46. Tozer, T. N., Rigod, J., McLeod, A. D., Gungon, R., Hoag, M. K., and Friend, D. R., Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig, Pharm. Res., 8, 445, 1991.
47. Kimura, T., Yamaguchi, T., Usuki, K., Kurosaki, Y., Nakayama, T., Fujimara, Y., Matsuda, Y., Unno, K., and Suzuki, T., Colonic mucosa-specific "pro-amedrugs" for oral treatment of ulcerative colitis: design, synthesis and fate of methyl 20-glucopyranosyloxyprednisolonates, J. Control. Rel., 30, 125, 1994.
48. Larsen, C., Harboe, E., Johansen, M., and Olesen, H. P., Macromolecular prodrugs. XVI. Colon-targeted delivery - comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract, Pharm. Res., 6, 995, 1989.
49. McLeod, A. D., Friend, D. R., and Tozer, T. N., Synthesis and chemical stability of glucocorticoid-dextran esters; potential prodrugs for colon-specific delivery, Int. J. Pharmacol., 92, 105, 1993.
50. Moore, W. E. C. and Holdeman, L. V., Discussion of current bacteriologic investigations of the relationships between intestinal flora, diet and colon cancer, Cancer Res., 35, 3418, 1975.
51. Moore, W. E. C. and Holdeman, L. V., Human faecal flora: the flora of 20 Japanese-Hawaiians. Appl. Microbiol., 27, 961, 1974.
52. Schröder, H. and Johansson, A. K., Redox potential in cecal contents of the rat and azo reduction of salicyl-azo-sulphapyridin, Xenobiotica, 3, 233, 1973.
53. Gorbach, S. L., Nahas, L., Lerner, P. I., and Weinstein, L., Studies of intestinal microflora. I. Effects of diet, age periodic sampling on numbers of faecal microorganisms in man, Gastroenterology, 53, 845, 1967.
54. Gorbach, S. L., Plaut, A. G., Nahas, L., Weinstein, L., Spanknebel, G., and Levitan, R., Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and faecal flora, Gastroenterology, 53, 856, 1967.
55. Finegold, S. M., Sutter, V. L., and Mathisen, G. E., Normal indigenous intestinal flora, in Human Intestinal Microflora in Health and Disease, Hentges, D. J., Ed., Academic Press, London, 1983, 3.
56. Friend, D. R., Chow, J. J., and Chang, G. W., Effect of antibiotic pretreatment on glycosidase-based colonic drug delivery, Drug Design Del., 6, 311, 1990.
57. Goldin, B. and Gorbach, S. L., Alterations in faecal microflora enzymes related to diet, age, lactobacillus supplements, and dimethylhydrazine, Cancer, 40, 2421, 1977.
58. Drasar, B. S., Shiner, M., and McLeod, G. M., Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons, Gastroenterology, 56, 71, 1969.
59. Wrong, O. M., Edmonds, C. J., and Chadwick, V. S., The Large Intestine: Its Role in Mammalian Nutrition and Homeostasis, Halsted Press, New York, 1981.
60. Englyst, H. N., Hay, S., and Macfarlane, G. T., Polysaccharide breakdown by mixed populations of human faecal bacteria, FEMS Microbiol. Ecol., 45, 163, 1987.
61. Englyst, H. N. and Cummings, J. H., Digestion of the polysaccharides of some cereal foods in the human small intestine, Am. J. Clin. Nutr., 42, 778, 1985.
62. Wolin, M. J. and Miller, T. L., Interactions of microbial populations in cellulose fermentation. Fed. Proc., 42, 109, 1983.
63. Bergman, E. N., Energy contribution of volatile fatty acids from the gastrointestinal tract in various species, Physiol. Rev., 70, 567, 1990.
64. Mortensen, P. B., Hove, H., Clausen, M. R., and Holtug, K., Fermentation to short-chain fatty acids and lactate in human faecal batch cultures, Scand. J. Gastroenterol., 26, 1285, 1991.
65. Mortensen, P. B., Clausen, M. R., Bonnén, H., Hove, H., and Holtug, K., Colonic fermentation of isphagula, wheat bran, glucose, and albumin to short-chain fatty acids and ammonia evaluated in vitro in 50 subjects, J. Parent. Enteral Nutr., 16, 433, 1992.
66. Salayers, A. A. and Leedle, J. A. Z., Carbohydrate metabolism in the human colon, in Human Intestinal Microflora in Health and Disease, Hentges, D. J., Ed., Academic Press, London, 1983, 129.
67. Nordgaard, I., Mortensen, P. B., and Langkilde, A. M., Small intestinal malabsorption and colonic fermentation of resistant starch and resistant peptides to short-chain fatty acids, Nutrition, in press, 1995.
68. Salayers, A. A., Bacteroides of the human lower intestinal tract, Annu. Rev. Microbiol., 38, 293, 1984.
69. The Merck Index, Budavari, S., Ed., Merck & Co., New Jersey, 1989.
70. Szejtli, J., Medical applications of cyclodextrins, Med. Res. Rev., 14, 353, 1994.
71. Goldin, B. R. and Gorbach, S. L., Alterations of the intestinal microflora by diet, oral antibiotics, and Lactobacillus: decreased production of free amines from aromatic nitrocompounds, azo dyes and glucuronides, J. Natl. Cancer Inst., 73, 689, 1981.
72. Kopecek, J. and Kopeckova, P., N-(2-hydroxypropyl)methacrylamide copolymers for colonspecific drug delivery, in Oral Colon-Specific Drug Delivery, Friend, D. R., Ed., CRC Press, Boca Raton, 1992, 190.
73. Haeberlin, B., Rubas, W., Nalen III, H. W., and Friend, D. R., In vitro evaluation of dexamethasone-β-D-glucuronide for colon-specific drug delivery, Pharm. Res., 10, 1553, 1993.
74. Hehre, E. J. and Sery, T. W., Dextran-splitting anaerobic bacteria from the human intestine, J. Bacteriol., 63, 424, 1952.
75. Sery, T. W. and Hehre, E. J., Degradation of dextrans by enzymes of intestinal bacteria, J. Bacteriol., 71, 373, 1955.
76. Harboe, E., Larsen, C., and Johansen, M., Macromolecular prodrugs. X. Bioavailability of naproxen after oral administration of dextran-naproxen ester conjugates in rabbits, Farmaci Sci. Ed., 16, 65, 1988.
77. Harboe, E., Johansen, M., and Larsen, C., Macromolecular prodrugs. VI. Coupling of naproxen to dextrans and in vitro characterization of the conjugates, Farmaci Sci. Ed., 16, 73, 1988.
78. Harboe, E., Larsen, C., Johansen, M., and Olesen, H. P., Macromolecular prodrugs. XIV. Absorption characteristics of naproxen after oral administration of a dextran T-70-naproxen ester prodrug in pigs, Int. J. Pharmacol., 53, 157, 1989.
79. McLeod A., D., Dextran prodrugs for colon-specific drug delivery, in Oral Colon-Specific Drug Delivery, Friend, D. R., Ed., CRC Press, Boca Raton, 1992, 213.
80. Vercauteren, R., Bruneel, D., and Schacht, E., Effect of the chemical modification of dextran on the degradation by dextranase, J. Bioact. Compat. Polymer., 5, 4, 1990.
81. Milojevic, S., Newton, J. M., Cummings, J. H., Gibson, G., Botham, R. L., Ring, S. G., Allwood, M., and Stockham, M., Amylose, the new perspective in oral drug delivery to the human large intestine, STP Pharma. Sci., 5, 47, 1995.
82. Antenucci, R. N. and Palmer, J. K., Enzymatic degradation of α- and β-cyclodextrins by Bacteroides in the human colon, J. Agric. Food Chem., 32, 1316, 1984.
83. Siefke, V., Weckenmann, H. P., and Bauer, K. H., b-Cyclodextrin matrix films for colon-specific drug delivery, Proc. Intern. Symp. Rel. Bioact. Mater., 20, 182, 1993.
84. Lehmann, K. O. R. and Dreher, K. D., Methacrylate-galactomannan coating for colonspecific drug delivery. Proc. Intern. Symp. Rel. Bioact. Mater., 18, 331, 1991.
85. Sarkolitis, A. W. and Bauer, K. H., Synthese und untersuchung von polyurethanen mit galactomannan-segmenten als hilfsstoffe zur freisetzung von peptid-arnzneistoffen im dickdarm, Pharm. Ind., 54, 873, 1992.
86. Brøndsted, H., Hydrogels for colon-specific peptide delivery, Ph.D. thesis, University of Utah, 1991.
87. Rubinstein, A. and Sintov, A., Biodegradable polymeric matrices with potential specificity to the large intestine, in Oral Colon-Specific Drug Delivery, Friend, D. R., Ed., CRC Press, Boca Raton, 1992, 233.
88. Ashford, M., Fell, J., Attwood, D., Sharma, H., and Woodhead, P., An evaluation of pectin as a carrier for drug targeting to the colon. J. Control. Rel., 26, 213, 1993.
89. Ashford, M., Fell, J., Attwood, D., Sharma, H., and Woodhead, P., Studies on pectin formulations for colon drug delivery, J. Control. Rel., 30, 225, 1994.
90. Rubinstein, A., Nakar, D., and Sintov, A., Chondroitin sulfate: a potential biodegradable carrier for colon-specific drug delivery, Int. J. Pharmacol., 84, 141, 1992.
91. Rubinstein, A., Nakar, D., and Sintov, A., Colonic drug delivery: enhanced release of indomethacin from cross linked chondroitin matrix in rat cecal content, Pharm. Res., 9, 276, 1992.
92. Hovgaard, L. and Brøndsted, H., Dextran hydrogels for colon-specific drug delivery, J. Control. Rel., 36, 159, 1995.
93. Brøndsted, H., Hovgaard, L., and Simonsen, L., Dextran hydrogels for colon-specific drug delivery. II. Synthesis and characterization, Eur. J. Pharm. Biopharm., 42, 85, 1996.
94. Brøndsted, H., Hovgaard, L., and Simonsen, L., Dextran hydrogels for colon-specific drug delivery. III. In vitro and in vivo degradation, STP Pharma. Sci., 5, 60, 1995.
95. Simonsen, L., Hovgaard, L., Mortensen, P. B., and Brøndsted, H., Dextran hydrogels for colon-specific drug delivery, V. Degradation in human intestinal incubation models, Eur. J. Pharm. Sci., 3, 329, 1995.
96. Brøndsted, H., Hovgaard, L., and Simonsen, L., Dextran hydrogels for colon-specific drug delivery. IV. Comparative release study of hydrocortisone and prednisolone sodium phosphate. STP Pharma. Sci., 5, 65, 1995.
97. Østberg, T. and Graffner, C., Calcium alginate matrices for oral multiple unit administration. III. Influence of calcium concentration, amount of drug added and alginate characteristics on drug release, Int. J. Pharmacol., 111, 271, 1994.
98. Rubinstein, A., Radai, R., Ezra, M., Pathak, S., and Roken, J. S., In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier, Pharm. Res., 10, 258, 1993.
99. Rubinstein, A. and Gliko-Kabir, I., Synthesis and swelling-dependent enzymatic degradation of borax-modified guar gum for colonic delivery purposes, STP Pharma. Sci., 5, 41, 1995.
100. Macfarlane, G. T., Hay, S., Macfarlane, S., and Gibson, G. R., Effect of different carbohydrates on growth, polysaccharidase and glycosidase production by Bacteroides ovatus, in batch and continuous culture, J. Appl. Bacterol., 68, 179, 1990.
101. Grim, Y. and Kopecek, J., Bioadhesive water-soluble polymeric drug carriers for sitespecific oral drug delivery: synthesis, characterization and release of 5-aminosalicylic acid by Streptococcus faecium in vitro, N. Polymer. Mater., 3, 49, 1991.
102. Hardy, J. G., Scintigraphic techniques on studying colonic drug absorption, in Colonic Drug Absorption and Metabolism, Bieck, P. R., Ed., Marcel Dekker, New York, 1993, 77.
103. Wilson, C. G., Application of gamma scintigraphy to modern dosage form design, Eur. J. Pharm. Sci., 2, 47, 1994.
104. Wilding, I. R., Pharmacoscintigraphic evaluation of oral delivery systems: part 1, Pharm. Tech. Eur., 6, 19, 1994.